Prot# C0701a/204/ON/US: A Randomized, Open-Label Study of Oral CEP-701 Administered in Sequence With Standard Chemotherapy to Patients With Relapsed Acute Myeloid Leukemia (AML) Expressing FLT-3 Activating Mutations

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/5/04 → 2/1/12

Funding

  • Cephalon, Inc. (C0701a/204/ON/US)